Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study to investigate the safety, efficacy and pharmacokinetics of EYN-1601
for dilation of the pupil. A single microdose of EYN-1601 will be compared to single doses of
commercially available phenylephrine hydrochloride 2.5% and 10% ophthalmic solutions.